CA Patent

CA2895512C — Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration

Assigned to Parion Sciences Inc · Expires 2021-10-19 · 5y expired

What this patent protects

This invention provides compounds of the formula (I) and their pharmaceutically acceptable salts, useful as sodium channel blockers, compositions containing the same, therapeutic methods and uses for the same and processes for preparing the same.

USPTO Abstract

This invention provides compounds of the formula (I) and their pharmaceutically acceptable salts, useful as sodium channel blockers, compositions containing the same, therapeutic methods and uses for the same and processes for preparing the same.

Drugs covered by this patent

Patent Metadata

Patent number
CA2895512C
Jurisdiction
CA
Classification
—
Expires
2021-10-19
Drug substance claim
No
Drug product claim
No
Assignee
Parion Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.